16 results  1 of 1 

1 Effect of 7-day Bismuth Quadruple Therapy versus 14-day Moxifloxacin Triple Therapy for Second-line Helicobacter pylori Eradication Therapy
Sung Eun Kim, Ji Hun Roh, Moo In Park, Seun Ja Park, Won Moon, Jae Hyun Kim, Kyoungwon Jung, Jae Joon Heo
Korean J Gastroenterol.2019;73(1):26-34.   Published online 2019 January 25     DOI: http://dx.doi.org/10.4166/kjg.2019.73.1.26
      
2 An unusual dual hypersensitivity reaction to moxifloxacin in a patient
Semra Demir, Derya Unal, Muge Olgac, Nilgun Akdeniz, Esin Aktas-Cetin, Asli Gelincik, Bahauddin Colakoglu, Suna Buyukozturk
Asia Pac Allergy.2018;8(3):e26.  Published online 2018 July 17     DOI: http://dx.doi.org/10.5415/apallergy.2018.8.e26
      
3 The Efficacy of Moxifloxacin-containing Triple Therapy after Hybrid Therapy Failure in Helicobacter pylori Eradication
Soohoon Kwon, Dong Ho Lee, Jae Bin Kang, Nayoung Kim, Young Soo Park, Cheol Min Shin, Hyuk Yoon, Yoon Jin Choi
Korean J Gastroenterol.2017;70(2):72-80.   Published online 2017 August 25     DOI: http://dx.doi.org/10.4166/kjg.2017.70.2.72
      
4 A Multicenter, Randomized, Open, Comparative Study for the Efficacy and Safety of Oral Moxifloxacin 400 mg Once a Day and Clarithromycin 500 mg Twice Daily in Korean Patients with Acute Exacerbations of Chronic Bronchitis
Seung Joon Kim, Seok Chan Kim, Sook Young Lee, Hyeong Kyu Yoon, Tae Yon Kim, Young Kyoon Kim, Jeong Sup Song, Sung Hak Park, Ho Joong Kim, Man Pyo Chung, Gee Young Suh, O Jung Kwon, Shin Hyung Lee, Kyung Ho Kang, Eh Hyung Lee, Sung Chul Hwang, Myung Ho Ha
Tuberc Respir Dis.2000;49(6):740-751.   Published online 2016 March 11     DOI: http://dx.doi.org/10.4046/trd.2000.49.6.740
      
5 Multicenter Study of Antimicrobial Susceptibility of Anaerobic Bacteria in Korea in 2012
Yangsoon Lee, Yeon-Joon Park, Mi-Na Kim, Young Uh, Myung Sook Kim, Kyungwon Lee
Ann Lab Med.2015;35(5):479-486.   Published online 2015 July 15     DOI: http://dx.doi.org/10.3343/alm.2015.35.5.479
      
6 Low Serum Concentrations of Moxifloxacin, Prothionamide, and Cycloserine on Sputum Conversion in Multi-Drug Resistant TB
Seung Heon Lee, Kyung-Ah Seo, Young Min Lee, Hyun-Kyung Lee, Je Hyeong Kim, Chol Shin, Jong-Ryul Ghim, Jae-Gook Shin, Dong Hyun Kim
Yonsei Med J.2015;56(4):961-967.   Published online 2015 June 5     DOI: http://dx.doi.org/10.3349/ymj.2015.56.4.961
      
7 Outcomes and Use of Therapeutic Drug Monitoring in Multidrug-Resistant Tuberculosis Patients Treated in Virginia, 2009-2014
Scott K. Heysell, Jane L. Moore, Charles A. Peloquin, David Ashkin, Eric R. Houpt
Tuberc Respir Dis.2015;78(2):78-84.   Published online 2015 April 2     DOI: http://dx.doi.org/10.4046/trd.2015.78.2.78
      
8 Prediction of Pharmacokinetics and Penetration of Moxifloxacin in Human with Intra-Abdominal Infection Based on Extrapolated PBPK Model
LiQin Zhu, JianWei Yang, Yuan Zhang, YongMing Wang, JianLei Zhang, YuanYuan Zhao, WeiLin Dong
Korean J Physiol Pharmacol.2015;19(2):99-104.   Published online 2015 February 25     DOI: http://dx.doi.org/10.4196/kjpp.2015.19.2.99
      
9 Antimicrobial Susceptibility of Clinical Isolates of Bacteroides fragilis Group Organisms Recovered from 2009 to 2012 in a Korean Hospital
Jisook Yim, Yangsoon Lee, Myungsook Kim, Young Hee Seo, Wan Hee Kim, Dongeun Yong, Seok Hoon Jeong, Kyungwon Lee, Yunsop Chong
Ann Lab Med.2015;35(1):94-98.   Published online 2014 December 8     DOI: http://dx.doi.org/10.3343/alm.2015.35.1.94
      
10 Epithelial Wound Healing after Cataract Surgery Comparing Two Different Topical Fluoroquinolones
Kyung Eun Han, Woo Suk Chung, Tae-im Kim, Sekyung Kim, Terry Kim, Eung Kweon Kim
Yonsei Med J.2014;55(1):197-202.   Published online 2013 November 29     DOI: http://dx.doi.org/10.3349/ymj.2014.55.1.197
      
11 A Case of Fusarium Keratitis Treated with Moxifloxacin 0.5% Ophthalmic Solution
Dong Cheol Lee, Jung Won Lee, Sung Dong Chang
J Korean Ophthalmol Soc.2012;53(2):338-341.   Published online 2012 February 15     DOI: http://dx.doi.org/10.3341/jkos.2012.53.2.338
      
12 Moxifloxacin Mixed Augmented Amniotic Membrane Transplantation for Perforating Infectious Keratitis
Hong Kyun Kim
J Korean Ophthalmol Soc.2012;53(2):342-347.   Published online 2012 February 15     DOI: http://dx.doi.org/10.3341/jkos.2012.53.2.342
      
13 A Case of Stenotrophomonas maltophilia Keratitis Effectively Treated with Moxifloxacin
Sung Whan Son, Hyung Jin Kim, Jeong Won Seo
Korean J Ophthalmol.2011;25(5):349-351.   Published online 2011 September 20     DOI: http://dx.doi.org/10.3341/kjo.2011.25.5.349
      
14 A Study on the Mechanism of Immunomodulating Effects of Moxifloxacin in Oleic Acid-Induced Acute Lung Injury
Young Man Lee
Tuberc Respir Dis.2011;71(2):97-105.   Published online 2011 August 31     DOI: http://dx.doi.org/10.4046/trd.2011.71.2.97
      
15 Moxifloxacin Alleviates Oleic Acid-provoked Neutrophilic Respiratory Burst in the Rat Lung through the Inhibition of Cytosolic Phospholipase A2
Young Man Lee
Tuberc Respir Dis.2010;69(4):256-264.   Published online 2010 October 31     DOI: http://dx.doi.org/10.4046/trd.2010.69.4.256
      
16 Activity of Moxifloxacin Against Ofloxacin-Resistant Mycobacterium Tuberculosis: A Study of Cross-Resistance Between Ofloxacin and Moxifloxacin
Byoung Ju Kim, Young Soo Kang, Seung Kyu Park
Tuberc Respir Dis.2004;57(5):405-410.   Published online 2004 November 30     DOI: http://dx.doi.org/10.4046/trd.2004.57.5.405
      

 1 of 1